Luc St-Onge is Head of Business Development at apceth Biopharma and has over 20 years’ experience in business development and IP in the biopharmaceutical industry. Prior to joining apceth, Luc was Head of Business Development at Ganymed Pharmaceuticals during the acquisition of the company by Astellas Pharma. He is also a co-founder of ARRIDAD Therapeutics, a biotech company developing novel drugs for the treatment of diabetes and autoimmune diseases and was formerly Chief Business Officer at Affectis Pharmaceuticals and Director of Diabetes research at Develogen. Dr. St-Onge is a molecular biologist by training, and has worked with adult and embryonic stem cells during his scientific career. He has published over 25 articles in top journals such as Nature, Oncogene, PNAS, and has filed numerous patent applications.